荣昌生物：首次回购19.4144万股

Core Viewpoint - Rongchang Biotech announced the completion of its first share buyback on January 20, 2026, through the Shanghai Stock Exchange, repurchasing 194,144 shares, which represents 0.0344% of the company's total share capital, at a price range of 102.17 to 103.78 yuan per share, totaling 20.004 million yuan excluding transaction fees [1] Summary by Categories Share Buyback Details - The company executed a share buyback of 194,144 shares, accounting for 0.0344% of its total share capital [1] - The buyback price ranged from 102.17 yuan to 103.78 yuan per share [1] - The total amount spent on the buyback was 20.004 million yuan, which is within the anticipated range of 20 million to 40 million yuan [1] Purpose and Impact - The repurchased shares will be used for employee stock ownership plans or equity incentives [1] - The buyback is not expected to have a significant impact on the company's operational activities, financial status, or shareholding structure [1]